Roose E, Huysmans E, Lahousse A, Mostaqim K, van Gerven L, Vissers M
J Clin Med. 2023; 12(18).
PMID: 37762721
PMC: 10531632.
DOI: 10.3390/jcm12185780.
Lee S, Woo S, Oh E, Park M
Qual Life Res. 2023; 33(1):241-252.
PMID: 37684352
DOI: 10.1007/s11136-023-03510-1.
Fitting S, McRae M, Hauser K
J Neuroimmune Pharmacol. 2020; 15(4):584-627.
PMID: 32876803
PMC: 7463108.
DOI: 10.1007/s11481-020-09941-8.
Fathi H, Yoonessi A, Khatibi A, Rezaeitalab F, Rezaei-Ardani A
Addict Health. 2020; 12(2):140-158.
PMID: 32782736
PMC: 7395935.
DOI: 10.22122/ahj.v12i2.249.
Koffel E, Kats A, Kroenke K, Bair M, Gravely A, DeRonne B
Pain Med. 2019; 21(6):1162-1167.
PMID: 31529104
PMC: 7069777.
DOI: 10.1093/pm/pnz221.
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.
Koob G, Colrain I
Neuropsychopharmacology. 2019; 45(1):141-165.
PMID: 31234199
PMC: 6879503.
DOI: 10.1038/s41386-019-0446-0.
The association between insomnia and prescription opioid use: results from a community sample in Northeast Florida.
Serdarevic M, Osborne V, Striley C, Cottler L
Sleep Health. 2017; 3(5):368-372.
PMID: 28923194
PMC: 5657579.
DOI: 10.1016/j.sleh.2017.07.007.
Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population.
Zheng W, Wakim R, Geary R, Lander L, Wen S, Xiao M
Austin J Drug Abuse Addict. 2017; 3(1).
PMID: 28133635
PMC: 5270620.
One Month of Oral Morphine Decreases Gray Matter Volume in the Right Amygdala of Individuals with Low Back Pain: Confirmation of Previously Reported Magnetic Resonance Imaging Results.
Lin J, Chu L, Stringer E, Baker K, Sayyid Z, Sun J
Pain Med. 2016; 17(8):1497-504.
PMID: 26814280
PMC: 4921346.
DOI: 10.1093/pm/pnv047.
A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
Nordmann S, Lions C, Vilotitch A, Michel L, Mora M, Spire B
Psychopharmacology (Berl). 2016; 233(7):1203-13.
PMID: 26753792
DOI: 10.1007/s00213-016-4202-4.
Incorporating measures of sleep quality into cancer studies.
Redeker N, Pigeon W, Boudreau E
Support Care Cancer. 2014; 23(4):1145-55.
PMID: 25510361
PMC: 4346497.
DOI: 10.1007/s00520-014-2537-0.
Fighting insomnia and battling lethargy: the yin and yang of palliative care.
Davis M, Goforth H
Curr Oncol Rep. 2014; 16(4):377.
PMID: 24535303
DOI: 10.1007/s11912-014-0377-1.
Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies.
Dimsdale J, Ball E, Carrier E, Wallace M, Holman P, Mulroney C
Support Care Cancer. 2010; 19(12):2015-20.
PMID: 21116652
PMC: 3204044.
DOI: 10.1007/s00520-010-1052-1.
Subjective daytime sleepiness and daytime function in patients on stable methadone maintenance treatment: possible mechanisms.
Wang D, Teichtahl H, Goodman C, Drummer O, Grunstein R, Kronborg I
J Clin Sleep Med. 2008; 4(6):557-62.
PMID: 19110885
PMC: 2603533.
Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer.
Olson K, Turner A, Courneya K, Field C, Man G, Cree M
Support Care Cancer. 2007; 16(3):241-9.
PMID: 17647028
DOI: 10.1007/s00520-007-0298-8.
The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients.
Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Gennatas K, Smyrniotis V
Sleep. 2007; 30(6):737-42.
PMID: 17580595
PMC: 1978346.
DOI: 10.1093/sleep/30.6.737.
Sleep disorders in advanced cancer patients: prevalence and factors associated.
Mercadante S, Girelli D, Casuccio A
Support Care Cancer. 2004; 12(5):355-9.
PMID: 15064937
DOI: 10.1007/s00520-004-0623-4.